Pay in 4 interest-free payments of $5.22 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
To translate these findings into human disease, we took advantage of the widespread use of GLP-1 receptor agonists for the treatment of type 2 diabetes and available clinical information in electronic health record data. Researchers conducted a retrospective cohort study using electronic health records to identify 5,940 adults with asthma and type 2 diabetes who were newly prescribed GLP-1 receptor agonists or comparator drugs from January 2000 to March 2018
(download PDF Flow chart of the data sources in the study
ABCG2 Inhibitors Febuxostat is a common drug for the treatment of gout
QALYs are measures of benefit that account for both the quantity and quality of life lived
US$ 23.54
US$ 28.35
US$ 29.58
US$ 27.80
US$ 27.24
US$ 26.80
US$ 28.20
